Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 1/2007

01.02.2007

Delay in invasive risk stratification of women with acute coronary syndrome is associated with worse outcomes

verfasst von: Mouaz Husayn Al-Mallah, Rasha N. Bazari, Sanjaya Khanal

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Invasive risk stratification in patients with acute coronary syndromes (ACS) has been shown to improve outcomes. There is paucity of data on women undergoing invasive risk stratification. We investigated whether the time to coronary angiography affects survival of female patients admitted with ACS.

Method

Female patients admitted to the coronary intensive care unit with ACS between 1/1/97 and 12/31/00 and undergoing coronary angiography during same hospitalization were divided into three groups based on the time to angiography: same day, 1–2 days and >2 days. The baseline clinical features, angiography results and outcomes were compared between the angiography groups.

Results

Of the total 350 female patients who fulfilled the inclusion criteria, 63% underwent angiography within two days of presentation. Three year mortality rates in women undergoing angiography on the same day, 1–2 days and >2-days were 7%, 7% and 22% respectively (p = 0.001). Using multivariate analysis, angiography beyond 2 days was a significant predictor of mortality among women (OR 2.6, 95% CI 1.3–5.0, p = 0.006) after adjusting for confounding variables.

Conclusion

Later invasive risk stratification after 2 days of presentation in women with ACS is associated with worse survivial. Gender should not be a reason to defer early coronary angiography in these patients.
Literatur
1.
Zurück zum Zitat The World Health Report (2003) The World Health Organization (WHO) The World Health Report (2003) The World Health Organization (WHO)
2.
Zurück zum Zitat Bloomkalns A, Chen A, Hochman J et al (2005) Disparities in the diagnosis and treatment of non-st-segment elevation acute coronary syndromes. Large scale observations from the CRUSADE. JACC 45:832–837 Bloomkalns A, Chen A, Hochman J et al (2005) Disparities in the diagnosis and treatment of non-st-segment elevation acute coronary syndromes. Large scale observations from the CRUSADE. JACC 45:832–837
3.
Zurück zum Zitat Wallentin L, Lagerqvist B, Husted S et al (2000) Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomized trial. Lancet 356:9–16PubMedCrossRef Wallentin L, Lagerqvist B, Husted S et al (2000) Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomized trial. Lancet 356:9–16PubMedCrossRef
4.
Zurück zum Zitat Fox K, Poole-Wilson P, Henderson R et al (2002) Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomized trial. Lancet 360:743–751PubMedCrossRef Fox K, Poole-Wilson P, Henderson R et al (2002) Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomized trial. Lancet 360:743–751PubMedCrossRef
5.
Zurück zum Zitat McCullough P, Gibson C, Dibattiste P et al (2004) Timing of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trial. J Interv Cardiol 17:81–86PubMedCrossRef McCullough P, Gibson C, Dibattiste P et al (2004) Timing of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trial. J Interv Cardiol 17:81–86PubMedCrossRef
6.
Zurück zum Zitat Cannon C, Weintraub W, Demopoulos L et al (2001) Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Eng J Med 344:1879–1887CrossRef Cannon C, Weintraub W, Demopoulos L et al (2001) Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Eng J Med 344:1879–1887CrossRef
7.
Zurück zum Zitat Braunwald E, Antman EM, Beasley JW et al (2002) ACC/AHA guidelines for the management of patients with unstable angina and non-st-segment elevation myocardial infarction: executive summary and recommendation. J Am Coll Cardiol 40:1366–1374PubMedCrossRef Braunwald E, Antman EM, Beasley JW et al (2002) ACC/AHA guidelines for the management of patients with unstable angina and non-st-segment elevation myocardial infarction: executive summary and recommendation. J Am Coll Cardiol 40:1366–1374PubMedCrossRef
8.
Zurück zum Zitat Glaser R, Herrmann H, Murphy S et al (2002) Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA 288:3124–3129PubMedCrossRef Glaser R, Herrmann H, Murphy S et al (2002) Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA 288:3124–3129PubMedCrossRef
9.
Zurück zum Zitat Moriel M, Behar S, Tzivoni T et al (2005) Management and outcomes of elderly women and men with acute coronary syndromes in 2000 and 2002. Arch Intern Med 165:1521–1525PubMedCrossRef Moriel M, Behar S, Tzivoni T et al (2005) Management and outcomes of elderly women and men with acute coronary syndromes in 2000 and 2002. Arch Intern Med 165:1521–1525PubMedCrossRef
10.
Zurück zum Zitat Al-Mallah M, Dajani K, Hudson M et al (2005) Long term outcomes based on time-to-angioplasty in patients admitted with non-ST-segment elevation acute coronary syndromes. J Inv Cardiol 5:251–255 Al-Mallah M, Dajani K, Hudson M et al (2005) Long term outcomes based on time-to-angioplasty in patients admitted with non-ST-segment elevation acute coronary syndromes. J Inv Cardiol 5:251–255
Metadaten
Titel
Delay in invasive risk stratification of women with acute coronary syndrome is associated with worse outcomes
verfasst von
Mouaz Husayn Al-Mallah
Rasha N. Bazari
Sanjaya Khanal
Publikationsdatum
01.02.2007
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 1/2007
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-006-9013-8

Weitere Artikel der Ausgabe 1/2007

Journal of Thrombosis and Thrombolysis 1/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.